Back to News
Market Impact: 0.35

Meta Is Spending $48 Billion With CoreWeave and Nebius. Which Neocloud Stock Is a Better Buy?

METANVDACRWVNBIS
Artificial IntelligenceTechnology & InnovationCompany FundamentalsCorporate EarningsCorporate Guidance & OutlookCredit & Bond MarketsPrivate Markets & VentureAnalyst Insights
Meta Is Spending $48 Billion With CoreWeave and Nebius. Which Neocloud Stock Is a Better Buy?

Meta committed $21 billion to CoreWeave and up to $27 billion to Nebius to secure AI cloud capacity, highlighting continued demand for Nvidia GPU access and neocloud services. CoreWeave issued $6.25 billion of additional debt and Nebius issued $8.3 billion in debt this year to fund data center build-outs, while both remain loss-making despite rapid revenue growth of 168% to $5.1 billion for CoreWeave and 479% to $530 million for Nebius. The article argues CoreWeave appears less expensive relative to Nebius on valuation, but both face uncertainty as hyperscalers build more of their own AI infrastructure.

Analysis

The market’s real signal here is not “AI demand is strong,” but that hyperscalers are temporarily outsourcing capacity while they retool their own stacks. That creates a short window where neoclouds can print growth, but it also commoditizes them faster: once Meta and peers finish absorbing more of the GPU supply chain and custom silicon ramps, the bargaining power shifts back to the buyers. In other words, this is a cyclical capacity bottleneck trade, not yet a durable platform monopoly. The second-order winner is Nvidia, which benefits from both direct GPU demand and the financing urgency of its ecosystem partners. But the more interesting implication is for the debt markets: long-dated, contract-backed financing for AI data centers can keep spreads artificially tight until one large customer re-prices or delays an expansion. If build-out timelines slip, equity gets hit first, but the real pain can migrate into the bonds once leverage is set against still-immature cash flow. Relative value is the cleanest way to express the view. CoreWeave appears less fragile operationally because it is closer to scale, but that same scale means the market will punish any capacity miss or margin compression more aggressively. Nebius has more operating torque, but the combination of higher dilution risk and earlier-stage execution makes it a worse risk-adjusted asset if growth decelerates even modestly. The consensus is likely overestimating how long hyperscalers will tolerate paying a premium for outside capacity once their own capex cadence normalizes. Catalyst timing matters: over the next 1-2 quarters, watch for evidence of contract-backed financing being used to front-load growth; over 6-12 months, watch for a slowdown in order visibility as proprietary accelerator deployment increases. The key tail risk is not demand collapse but customer concentration—one Meta scheduling shift can change the narrative for both stocks in a single quarter. If the stock reaction to any capacity-delay headline repeats, that confirms this is still a momentum-driven, not fundamentals-driven, tape.